, EASL clinical practice guidelines: Management of chronic hepatitis B virus infection, J Hepatol, vol.57, pp.167-85, 2012.

D. E. Morisky, L. W. Green, and D. M. Levine, Concurrent and predictive validity of a self-reported measure of medication adherence, Med Care, vol.24, pp.67-74, 1986.

C. Koh, X. Zhao, N. Samala, S. Sakiani, T. J. Liang et al., AASLD clinical practice guidelines: a critical review of scientifi c evidence and evolving recommendations, Hepatology, vol.58, pp.2142-52, 2013.

M. A. Van-der-sande, P. Waight, and M. Mendy, Long-term protection against carriage of hepatitis B virus after infant va ccination, J Infect Dis, vol.193, pp.1528-1563, 2006.

T. J. Peto, M. E. Mendy, Y. Lowe, E. L. Webb, H. C. Whittle et al., Effi cacy and eff ectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program, BMC Infect Dis, vol.14, p.7, 2014.

G. Chamie, D. Kwarisiima, and T. D. Clark, Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda, PLoS One, vol.9, p.84317, 2014.

R. González, K. Munguambe, and J. Aponte, High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey, HIV Med, vol.13, pp.581-88, 2012.

J. Cook, W. Xu, and M. Msellem, Mass screening and treatment on the basis of results of a Plasmodium falciparum-specifi c rapid diagnostic test did not reduce malaria incidence in Zanzibar, J Infect Dis, vol.211, pp.1476-83, 2014.

E. J. Mills, J. B. Nachega, and I. Buchan, Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis, JAMA, vol.296, pp.679-90, 2006.

P. Marcellin, F. Zoulim, and C. Hezode, Eff ectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year, prospective, real-world study in France, Dig Dis Sci, 2016.

, WHO. Global database on blood safety, 2015.

J. Bottero, A. Boyd, and J. Gozlan, Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, J Hepatol, vol.58, pp.473-78, 2013.

E. Feret, B. Larouze, B. Diop, M. Sow, W. T. London et al., Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal, Am J Epidemiol, vol.125, pp.140-189, 1987.

G. M. Dusheiko, B. A. Brink, J. D. Conradie, T. Marimuthu, and R. Sher, Regional prevalence of hepatitis B, delta, and human immunodefi ciency virus infection in southern Africa: a large population survey, Am J Epidemiol, vol.129, pp.138-183, 1989.

G. A. Beckett, G. Ramirez, and A. Vanderhoff, Early identifi cation and linkage to care of persons with chronic hepatitis B virus infectionthree, MMWR Morb Mortal Wkly Rep, vol.63, pp.399-401, 2012.

M. C. O'leary, M. Sarwar, and S. J. Hutchinson, The prevalence of hepatitis C virus among people of South Asian origin in Glasgowresults from a community based survey and laboratory surveillance, Travel Med Infect Dis, vol.11, pp.301-310, 2013.

S. Nayagam, L. Conteh, and E. Sicuri, Cost-eff ectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Glob Health, vol.4, pp.568-78, 2016.